Italy vs New Zealand: Access to anti-retroviral drugs, male
Italy
85.0%
in 2023
New Zealand
85.0%
in 2024
Italy rank
34th
New Zealand rank
34th
Access to anti-retroviral drugs, male over time
- Italy
- New Zealand
How they compare
Italy currently reports 85.0% against 85.0% in New Zealand, a difference of 0.0%.
The two have swapped places 1 time across 24 shared years of data; in 2000 it was New Zealand ahead.
Italy ranks 34th and New Zealand ranks 34th of 141 countries.
Italy has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Italy | New Zealand | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 49.0% | 41.9% | 7.1% | Italy |
| 2010s | 74.0% | 63.7% | 10.3% | Italy |
| 2020s | 85.8% | 78.8% | 7.0% | Italy |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Italy or New Zealand?
- Italy, at 85.0% against 85.0% in New Zealand as of 2023.
- What is the difference in access to anti-retroviral drugs, male between Italy and New Zealand?
- 0.0%, with Italy ahead.
- How many years of comparable data are there for Italy and New Zealand?
- 24 years are reported by both, from 2000 to 2023.
- How do Italy and New Zealand rank globally for access to anti-retroviral drugs, male?
- Italy ranks 34th and New Zealand ranks 34th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.